Skip to main content
Back to News
Xlue raises $35 million to develop a clinical foundation model
Funding
2 min read

Xlue raises $35 million to develop a clinical foundation model

The AMW Read

The funding adds a company-level update to clinical AI, while prospective evidence and the reported evaluation details remain limited.
NoveltySignificance
Healthcare & Bio · Player Map
Xlue
Xlue

AI in Healthcare

View Company Profile

Xlue raises $35 million to develop a clinical foundation model

Xlue disclosed $35 million in funding for clinical intelligence work and published a technical report on its human health foundation model. The model represents patient trajectories as changing health states and treatment actions. Xlue says it is conducting prospective disease-risk studies across multiple health systems and working with pharmaceutical companies to identify new indications for existing drugs.

The funding adds a new company to the healthcare AI market, where clinical models must establish value through evidence and adoption. Xlue's approach focuses on predicting changes in health and responses to treatment. The company reports that its model outperformed frontier token-based systems in blind third-party evaluations at less than 0.1% of their compute cost. Those results are company-reported; the supplied coverage does not describe the evaluation methods or results in detail.

For builders and investors, the prospective studies offer a way to assess whether the model's predictions hold up in real clinical settings. Xlue also proposes offline trial simulations that compare modeled outcomes under drug treatment and control or standard care. Evidence that such simulations improve cohort selection or trial design would be relevant to drug developers; the reported work does not yet establish those outcomes.

#HealthcareAI #ClinicalAI #FoundationModels #DrugDevelopment #AIFunding

#Xlue#clinical foundation model#health-state modeling#drug development#related:Conviction

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3d agoXlue raises $35 million to develop a clinical foundation model · THIS ARTICLE
  2. 4d agoIsomorphic Labs raises $5 billion Series C for AI drug discoveryIsomorphic Labs
  3. 0mo agoPathos AI raises $237M to scale Foundry and advance four oncology assetsPathos
  4. 0mo agoWarp Sciences, founded by former OpenAI science lead Kevin Weil, raises $215M to automate drug-chemistry labsWarp Sciences

More news from Xlue

Stay updated with the latest news and announcements from Xlue.

View all Xlue news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard